Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Feb-24 5:00 PM View:  | Cullinan Oncology, Inc. (CGEM) | 22-Feb-24 | Grant | 160,000 | -- | -- | 143% 111.55K to 271.55K | |
| 27-Dec-23 6:30 PM View: | Cullinan Oncology, Inc. (CGEM) | 26-Dec-23 | Sale | 4,272 | $9.24 | $39,473.30 | (4%) 115.82K to 111.55K | |
| 29-Jun-23 4:59 PM View: | Cullinan Oncology, Inc. (CGEM) | 28-Jun-23 | Sale | 759 | $11.40 | $8,652.60 | (< 1%) 116.58K to 115.82K | |
| 24-May-23 4:36 PM View: | Cullinan Oncology, Inc. (CGEM) | 23-May-23 | Sale | 707 | $9.15 | $6,469.05 | (< 1%) 117.29K to 116.58K | |
| 26-Apr-23 4:23 PM View: | Cullinan Oncology, Inc. (CGEM) | 25-Apr-23 | Sale | 716 | $10.59 | $7,582.44 | (< 1%) 118.0K to 117.29K | |
| 27-Mar-23 4:05 PM View: | Cullinan Oncology, Inc. (CGEM) | 23-Mar-23 | Sale | 706 | $10.51 | $7,420.06 | (< 1%) 118.71K to 118.0K | |
| 23-Feb-23 5:06 PM View: | Cullinan Oncology, Inc. (CGEM) | 22-Feb-23 | Grant | 109,000 | -- | -- | 1123% 9.71K to 118.71K | |
| 05-Jul-22 6:04 PM View: | Cullinan Oncology, Inc. (CGEM) | 30-Jun-22 | Grant | 1,620 | $10.90 | $17,658.00 | 20% 8.09K to 9.71K | |
| 07-Jun-22 4:33 PM View: | Cullinan Oncology, Inc. (CGEM) | 06-Jun-22 | Private Purchase | 8,090 | $12.40 | $100,316.00 | 100% 0 to 8.09K | |
| 05-Jan-21 8:13 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-20 | Payment of Exercise | 7,660 | $62.03 | $475,150.00 | (16%) 48.52K to 40.85K | |
| 05-Jan-21 8:13 PM View: | Bristol-Myers Squibb Co. (BMY) | 31-Dec-20 | Option Exercise | 14,946 | -- | -- | 45% 33.57K to 48.52K | |
| 03-Dec-20 8:24 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-20 | Payment of Exercise | 3,380 | $62.18 | $210,168.00 | (9%) 36.95K to 33.57K | 1% |
| 03-Dec-20 8:24 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-20 | Option Exercise | 6,594 | -- | -- | 22% 30.36K to 36.95K | |
| 03-Nov-20 4:28 PM View: | Bristol-Myers Squibb Co. (BMY) | 30-Oct-20 | Payment of Exercise | 2,291 | $58.45 | $133,909.00 | (7%) 32.65K to 30.36K | (5%) |
| 03-Nov-20 4:28 PM View: | Bristol-Myers Squibb Co. (BMY) | 30-Oct-20 | Option Exercise | 4,650 | -- | -- | 17% 28.0K to 32.65K | |
| 05-May-20 4:49 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-May-20 | Payment of Exercise | 1,433 | $60.26 | $86,352.60 | (5%) 29.43K to 28.0K | (< 1%) |
| 05-May-20 4:49 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-May-20 | Option Exercise | 2,908 | -- | -- | 11% 26.52K to 29.43K | |
| 03-Mar-20 8:04 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-20 | Payment of Exercise | 8,473 | $59.06 | $500,415.00 | (24%) 34.99K to 26.52K | (2%) |
| 03-Mar-20 8:04 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-20 | Option Exercise | 17,204 | -- | -- | 97% 17.79K to 34.99K | |
| 06-Feb-20 8:48 PM View: | Bristol-Myers Squibb Co. (BMY) | 04-Feb-20 | Payment of Exercise | 1,071 | $64.29 | $68,854.60 | (6%) 18.86K to 17.79K | 7% |
| 06-Feb-20 8:48 PM View: | Bristol-Myers Squibb Co. (BMY) | 04-Feb-20 | Option Exercise | 2,076 | -- | -- | 12% 16.79K to 18.86K | |
| 27-Nov-19 5:31 PM View: | Bristol-Myers Squibb Co. (BMY) | 20-Nov-19 | Grant | 14,819 | -- | -- | 100% 0 to 14.82K | |
| 27-Nov-19 5:31 PM View: | Bristol-Myers Squibb Co. (BMY) | 20-Nov-19 | Grant | 1,966 | -- | -- | 13% 14.82K to 16.79K | |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 25,875 | -- | -- | 154% 16.79K to 42.66K | |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 40,694 | -- | -- | (95%) 42.66K to 1.97K | |
| 22-Nov-19 7:31 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 1,966 | -- | -- | (100%) 1.97K to 0 | |
| 04-Nov-19 4:05 PM View: | Celgene Corporation (CELG) | 31-Oct-19 | Payment of Exercise | 1,096 | $108.03 | $118,401.00 | (6%) 17.88K to 16.79K | |
| 04-Nov-19 4:05 PM View: | Celgene Corporation (CELG) | 31-Oct-19 | Option Exercise | 3,281 | -- | -- | 22% 14.6K to 17.88K | |
| 06-May-19 4:05 PM View: | Celgene Corporation (CELG) | 02-May-19 | Payment of Exercise | 490 | $95.21 | $46,652.90 | (3%) 15.09K to 14.6K | |
| 06-May-19 4:05 PM View: | Celgene Corporation (CELG) | 02-May-19 | Option Exercise | 1,563 | -- | -- | 12% 13.53K to 15.09K | |
| 18-Dec-18 6:26 PM View: | Celgene Corporation (CELG) | 16-Dec-18 | Payment of Exercise | 1,477 | $68.20 | $100,731.00 | (10%) 14.9K to 13.42K | (33%) |
| 18-Dec-18 6:26 PM View: | Celgene Corporation (CELG) | 16-Dec-18 | Option Exercise | 3,000 | -- | -- | 25% 11.9K to 14.9K |